[go: up one dir, main page]

MX2022004262A - Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. - Google Patents

Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Info

Publication number
MX2022004262A
MX2022004262A MX2022004262A MX2022004262A MX2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A
Authority
MX
Mexico
Prior art keywords
compositions
methods
enhancing health
wellbeing
enhancing
Prior art date
Application number
MX2022004262A
Other languages
English (en)
Inventor
William Kleidon
Original Assignee
Ojai Energetics Pbc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ojai Energetics Pbc filed Critical Ojai Energetics Pbc
Publication of MX2022004262A publication Critical patent/MX2022004262A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Las composiciones, métodos y equipos descritos en la presente pueden formularse como un suplemento nutricional o un suplemento dietético. La composición descrita en la presente puede proporcionar nutrientes o compuestos que de otro modo no se consumirían en cantidades suficientes en una dieta normal, y pueden contribuir al bienestar físico y al bienestar emocional de un sujeto.
MX2022004262A 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. MX2022004262A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762479091P 2017-03-30 2017-03-30
US201762506475P 2017-05-15 2017-05-15
US201862632965P 2018-02-20 2018-02-20

Publications (1)

Publication Number Publication Date
MX2022004262A true MX2022004262A (es) 2022-05-06

Family

ID=63676925

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019011510A MX2019011510A (es) 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud.
MX2022004262A MX2022004262A (es) 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019011510A MX2019011510A (es) 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud.

Country Status (11)

Country Link
US (1) US20200101041A1 (es)
EP (1) EP3600271A4 (es)
JP (3) JP2020512358A (es)
CN (1) CN110709069A (es)
AU (2) AU2018243694A1 (es)
BR (1) BR112019020554A2 (es)
CA (1) CA3057994A1 (es)
GB (1) GB2577810A (es)
IL (1) IL269642B1 (es)
MX (2) MX2019011510A (es)
WO (1) WO2018183115A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
ES2966110T3 (es) * 2018-04-04 2024-04-18 Vinsan Therapeutics Inc Formulaciones e instilados de cannabinoides tópicos, kits y métodos para tratar heridas tegumentarias y usos de los mismos
WO2019220324A2 (en) * 2018-05-14 2019-11-21 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid compositions and uses thereof in the treatment of infectious conditions
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
WO2020084450A1 (en) * 2018-10-23 2020-04-30 Radient Technologies Innovations Inc. Method of automating cannabis decarboxylation and extraction by recursive decarboxylation, sampling, and extraction steps
WO2020084425A1 (en) * 2018-10-24 2020-04-30 Radient Technologies Innovations Inc. Side effect and symptom relief
AU2019397508A1 (en) 2018-12-14 2021-06-24 Natural Extraction Systems, LLC Compositions and methods related to anionic cannabinoid molecules
US10959961B2 (en) * 2018-12-14 2021-03-30 Natural Extraction Systems, LLC Methods of administering anionic cannabinoid molecules dissolved in water
US10609944B1 (en) 2018-12-14 2020-04-07 Natural Extraction Systems, LLC Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
WO2020212951A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
US11759447B1 (en) 2019-06-26 2023-09-19 RCR BioPharma Compound and method for treating diseases and disorders
WO2021016710A1 (en) * 2019-07-30 2021-02-04 Tassili Life Sciences, Corp. Controlled release formulations of multiple active pharmaceutical agents, and psilocybe-derived agents in combination with cannabis-derived agents and methods for their use
US10780075B1 (en) 2019-07-31 2020-09-22 Etain IP, LLC Water soluble cannabis composition
CA3150979A1 (en) 2019-09-12 2021-03-18 Nulixir Inc. Controlled release core-shell particles and suspensions including the same
US12349706B2 (en) 2020-07-31 2025-07-08 Natural Extraction Systems, LLC Compositions and methods related to excipients and cannabinoid formulations
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
WO2022232093A1 (en) 2021-04-30 2022-11-03 Mind Medicine, Inc. Lsd salt crystal forms
US20220362319A1 (en) * 2021-05-12 2022-11-17 PPM Labs LLC Cannabinoid Concentration Process
AU2022331317B2 (en) 2021-08-19 2025-09-11 Definium Therapeutics US, Inc. IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
US12060328B2 (en) 2022-03-04 2024-08-13 Reset Pharmaceuticals, Inc. Co-crystals or salts of psilocybin and methods of treatment therewith
CN120213091B (zh) * 2025-05-28 2025-08-15 浙江机电职业技术大学 一种高温共烧结的多层异形陶瓷高温传感器及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400319B (en) * 2001-05-04 2005-06-08 Gw Pharma Ltd Cannabinoid-rich extracts
US8980940B2 (en) * 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids
EP4137142A1 (en) * 2013-03-14 2023-02-22 Purple Mundo, Inc. Bioactive concentrates and uses thereof
KR20160094950A (ko) * 2013-10-31 2016-08-10 풀 스펙트럼 래버러토리즈, 리미티드 테르펜 및 칸나비노이드 제제
AU2015335997B2 (en) * 2014-10-21 2020-10-01 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
US9375417B2 (en) * 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
EP3250200A4 (en) * 2015-01-31 2018-09-19 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
AU2016225026A1 (en) * 2015-02-27 2017-09-07 Canopy Growth Corporation Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
US9747740B2 (en) * 2015-03-02 2017-08-29 Ford Global Technologies, Llc Simultaneous button press secure keypad code entry
CA2995418A1 (en) * 2015-08-11 2017-02-16 KannaInnovations LLC Topical compositions comprising hydroxy acids and cannabinoids for skin care
WO2017193072A1 (en) 2016-05-06 2017-11-09 Harvest Direct Enterprises Llc The manufacturing methods, compositions, and medical applications of orally administered cannabis pharmaceuticals
CA3031810A1 (en) * 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
US20180344786A1 (en) * 2017-06-06 2018-12-06 NC3 Systems System and method enhanced cannabiniod effect delivery
CA3072519A1 (en) * 2017-09-28 2019-04-04 Canopy Growth Corporation Edible cannabinoid compositions

Also Published As

Publication number Publication date
AU2018243694A1 (en) 2019-10-17
AU2024203369A1 (en) 2024-06-06
GB201914076D0 (en) 2019-11-13
JP7624035B2 (ja) 2025-01-29
IL269642B1 (en) 2025-12-01
JP2025061440A (ja) 2025-04-10
US20200101041A1 (en) 2020-04-02
GB2577810A (en) 2020-04-08
JP2023139315A (ja) 2023-10-03
CA3057994A1 (en) 2018-10-04
EP3600271A4 (en) 2020-12-16
MX2019011510A (es) 2020-01-09
WO2018183115A1 (en) 2018-10-04
EP3600271A1 (en) 2020-02-05
IL269642A (en) 2019-11-28
BR112019020554A2 (pt) 2020-04-28
CN110709069A (zh) 2020-01-17
JP2020512358A (ja) 2020-04-23

Similar Documents

Publication Publication Date Title
MX2022004262A (es) Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.
MX2022012374A (es) Composiciones multi-suplementos.
IN2012DN00282A (es)
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
PH12015501688A1 (en) Nutritional compositions containing magnesium threonate and uses thereof
PH12016502368A1 (en) Potato based protein mixtures and nutritional compositions comprising potato protein
PH12013500716A1 (en) Age-tailored nutritional composition with animal fats and vegetable fats
MX2018015731A (es) Ingredientes de pienso que comprenden celulas microbianas lisadas.
MX2018005659A (es) Composiciones nutricionales que contienen butirato y usos de las mismas.
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
SG11201901114TA (en) Plant, method for producing plant, tolerance imparting method, tomato and method for producing tomato
ATE442050T1 (de) Nahrungsergänzungsmittel oder functional food enthaltend íl-kombination
MY179829A (en) Anti-regurgitation nutritional composition
MX381176B (es) Suplementos naturales enriquecidos por minerales.
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
PH12017500203A1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
PH12016501947A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2018002531A (es) Metodos para aumentar la absorcion de vitaminas liposolubles en la alimentacion.
PH12021551924A1 (en) A nutritional composition for use to enhance executive function
PH12019502354A1 (en) Composition containing a chloride salt for use in pregnant animals
GB2528406A (en) Prebiotic composition and method of its use
EA201992271A1 (ru) Способы и композиции для улучшения здоровья
ES2571427A1 (es) Productos lácteos enriquecidos con clorela y espirulina
PH22017001036U1 (en) Food supplement for the nervous system
PH12013000374A1 (en) A novel composition